1
/
of
1
AntibodySystem
SKU:DHD48499
Patritumab deruxtecan (ADC)
Patritumab deruxtecan (ADC)
Regular price
$4,510.00 USD
Regular price
Sale price
$4,510.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Catalog No.: DHD48499
| Catalog No. | DHD48499 |
|---|---|
| Product name | Patritumab deruxtecan (ADC) |
| Size | 5 mg |
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Description | Patritumab deruxtecan is an ADC consisting of a HER3-directed antibody and Dxd, a topoisomerase I inhibitor, used for the study of non-small cell lung cancer. |
| Form | Liquid |
| Purity | >90% as determined by SEC. |
| Clonality | Monoclonal |
| Target | HER3 |
| Purification | Purified by Ion Exchange Chromatography. |
| Endotoxin level | Please contact with the lab for this information. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| Alternative Names | HER3-DXd, U3-1287 |
| Clone ID | Patritumab deruxtecan |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
Share
